David Gill Net Worth & Insider Trades

David Gill - Director, Strongbridge Biopharma Plc

As of October 6, 2021

What is David Gill's Net Worth?

The current estimated net worth of Strongbridge Biopharma Plc's Director, David Gill, is estimated to be about $1.89M . David Gill owns about 74,896 units of Strongbridge Biopharma Plc common stock. In the last 2 years at Strongbridge Biopharma Plc, David Gill has sold an estimated value of $164.82K worth.

What is David Gill's Past Insider Trading?

David Gill's largest purchase order was 8,000 units , worth over $17.04K on September 28, 2020. In total, David Gill has made about 8 transactions over 2 years of their time at Strongbridge Biopharma Plc. David Gill usually trades in May and September, with the busiest year in 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is David Gill's' Mailing Address?

  • Mailing address is C/o Nxstage Medical Inc. (Nxtm) 439 South Union Street, 5th Floor Lawrence MA 01843 MA

What are Strongbridge Biopharma Plc's Past Insider Trades?

Strongbridge Biopharma Plc's most recent insider trade came on September 28, 2020 by David Gill who bought 8,000 units worth $17.04K . In the last 2 years, insiders at Strongbridge Biopharma Plc have sold an estimated value of $2.5M and bought an estimated value of $8.85M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are John Johnson, Chief Executive Officer,  Fredric Cohen, Chief Medical Officer,  and Richard Kollender, President and CFO .

Strongbridge Biopharma plc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1